T. Andrew Crockett
2019
In 2019, T. Andrew Crockett earned a total compensation of $3.3M as Chief Executive Officer at Carbylan Therapeutics, a 61% increase compared to previous year.
Compensation breakdown
| Bonus | $353,500 |
|---|---|
| Option Awards | $2,418,444 |
| Salary | $505,000 |
| Other | $11,000 |
| Total | $3,287,944 |
Crockett received $2.4M in option awards, accounting for 74% of the total pay in 2019.
Crockett also received $353.5K in bonus, $505K in salary and $11K in other compensation.
Rankings
In 2019, T. Andrew Crockett's compensation ranked 3,711th out of 13,971 executives tracked by ExecPay. In other words, Crockett earned more than 73.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,711 out of 13,971 | 73rd |
Division Manufacturing | 1,339 out of 5,695 | 77th |
Major group Chemicals And Allied Products | 465 out of 2,194 | 79th |
Industry group Drugs | 390 out of 1,880 | 79th |
Industry Pharmaceutical Preparations | 294 out of 1,392 | 79th |
Source: SEC filing on August 23, 2019.
Crockett's colleagues
We found three more compensation records of executives who worked with T. Andrew Crockett at Carbylan Therapeutics in 2019.